Skip to content

Zymeworks ZYME Shares Reserved for Future Issuance Under Stock Plans

Shares Reserved for Future Issuance Under Stock Plans at other companies

Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
6.7M+197%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
31.1M+12.3%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
64.8M+5.4%

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.79B+125%

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's shares reserved for future issuance under stock plans.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's shares reserved for future issuance under stock plans?
Zymeworks (ZYME) reported shares reserved for future issuance under stock plans of 6M in Q1 2026.
How has Zymeworks's shares reserved for future issuance under stock plans changed year-over-year?
Zymeworks's shares reserved for future issuance under stock plans increased by 12.0% year-over-year, from 5.3M to 6M.
What is the long-term trend for Zymeworks's shares reserved for future issuance under stock plans?
Over 4 years (2021 to 2025), Zymeworks's shares reserved for future issuance under stock plans has grown at a 51.5% compound annual growth rate (CAGR), from 952.6K to 5M.
What does shares reserved for future issuance under stock plans mean?
This represents the total number of common shares authorized and set aside for future issuance to employees and directors under equity compensation plans. It provides insight into the potential future dilution of existing shareholders. Investors monitor this to assess the firm's long-term incentive structure.